Historical record - last NADAC effective date: 1/22/2014
Product Information
AMPICILLIN 1 GM VIAL is a generic product labeled by Eugia US LLC, priced at $4.3059 per EA under NDC 55150011310. Its NADAC has been published 56 times since Jan 22, 2014.
FDA first approved this application on Aug 17, 2010. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 g/1
Manufacturer
Eugia US LLCNDC
55150011310
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
1/22/2014
Active Ingredients
AMPICILLIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065499FDA Approved
8/17/2010
TE Code
AP
On Market Since
2/1/2012
Pharmacological Classes
Price Statistics
The NADAC for AMPICILLIN 1 GM VIAL has been published 56 times since Jan 22, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3059 per EA |
|---|---|
| All-time high | $4.3059 (Feb 11, 2015) |
| All-time low | $4.3059 (Jan 22, 2014) |
| Median price | $4.3059 |
| Average price | $4.3059 |
| Largest weekly change | 0.0% (Jan 29, 2014) |
| Weeks tracked | 56 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Feb 11, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ampicillin Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ampicillin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMPICILLIN 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for AMPICILLIN 1 GM VIAL, manufactured by Eugia US LLC, is $4.3059 per EA (NDC 55150011310), effective Feb 11, 2015.
How has the price of AMPICILLIN 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for AMPICILLIN 1 GM VIAL has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for AMPICILLIN 1 GM VIAL?
Since Jan 22, 2014, the NADAC for AMPICILLIN 1 GM VIAL has ranged from a low of $4.3059 (Jan 22, 2014) to a high of $4.3059 (Feb 11, 2015), with a median of $4.3059 per EA.
Are there cheaper alternatives to AMPICILLIN 1 GM VIAL?
No other NADAC-published product currently shares the active ingredient and strength of AMPICILLIN 1 GM VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMPICILLIN 1 GM VIAL?
AMPICILLIN 1 GM VIAL (NDC 55150011310) is labeled by Eugia US LLC, and CMS classifies it as a generic product.